Sign in to fuzzto save your conversations, follow your research and come back anytime.
Natural Capsules
NATCAPSUQ
NSE
BSE
NSEBSESectorHealthcare
226.98
Loading chart…
NSEBSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
Natural Capsules returns to positive EBITDA as revenue recovers, but net losses continue amid a sharp rise in finance costs.
EBITDA recovered from ₹(2.33) Cr in Q3 FY26 to ₹1.12 Cr in Q1 FY27, marking a return to operational profitability.
Finance costs surged from ₹2.89 Cr in Q4 FY26 to ₹4.97 Cr in Q1 FY27, increasing debt servicing pressure.
EBITDA margins rebounded from (6.16)% in Q3 FY26 to 2.30% in Q1 FY27, reflecting improved cost efficiency.
Profit after tax remains negative at ₹(5.74) Cr in Q1 FY27, despite narrowing from ₹(7.12) Cr in Q3 FY26.
Revenue grew from ₹37.75 Cr in Q3 FY26 to ₹48.71 Cr in Q1 FY27, showing demand recovery after a mid-year dip.
Depreciation held steady at ₹4.33 Cr in Q1 FY27, consistent with ₹4.21 Cr in Q1 FY26, indicating stable asset utilization.
Other income jumped from ₹0.45 Cr in Q3 FY26 to ₹2.35 Cr in Q1 FY27, helping offset operational losses.
